Physician profile
Jonathan Ryan Obi
NPI 1497168751
$8,961.59
in general payments reported to CMS, 2019-2025
12 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $7,614 · 2021: $383 · 2022: $129 · 2023: $314 · 2024: $2.82 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,466.11 | 2020-2025 | Da Vinci Surgical System |
| Conmed Corporation | $124.32 | 2023 | Airseal |
| Integra Lifesciences Corporation | $95.13 | 2023 | Integra, Omnigraft, Surgimend |
| Baxter Healthcare | $67.47 | 2023-2025 | Perclot, Floseal |
| Innocoll Pharmaceuticals Limited | $43.71 | 2021 | |
| Kci USA, INC. | $38.33 | 2021 | |
| Davol INC. | $37.70 | 2021 | |
| Standard Bariatrics, INC. | $21.94 | 2022 | |
| Smith+Nephew, INC. | $17.39 | 2022 | |
| Kerecis Limited | $17.27 | 2022 | |
| Stryker Corporation | $16.65 | 2021 | |
| Heron Therapeutics, INC. | $15.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Obi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.